| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/0044011-200929001-00002 |
| P698 | PubMed publication ID | 19445550 |
| P2093 | author name string | Pierangelo Geppetti | |
| Silvia Benemei | |||
| P2860 | cites work | Morphine and alternative opioids in cancer pain: the EAPC recommendations | Q24648711 |
| Opioids: first lessons from knockout mice | Q33547877 | ||
| Drug interactions in palliative care | Q33891507 | ||
| Molecular mechanisms and regulation of opioid receptor signaling | Q33932163 | ||
| Opioid receptors | Q34326054 | ||
| The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers | Q34397089 | ||
| Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control | Q34481299 | ||
| Contribution to variability in response to opioids | Q34555917 | ||
| The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions | Q34586375 | ||
| Clinical pharmacology of opioids for pain | Q35024267 | ||
| Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs | Q35040927 | ||
| Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I. | Q35078460 | ||
| The fentanyl HCl patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting | Q36255041 | ||
| Efficacy and safety of scheduled dosing of opioid analgesics: a quality improvement study | Q36276083 | ||
| Drug interactions among commonly used medications. Chart simplifies data from critical literature review | Q36479346 | ||
| Morphine metabolites as novel analgesic drugs? | Q36615743 | ||
| Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction | Q36741881 | ||
| Opioid titration in cancer pain: a critical review | Q36748760 | ||
| Leukocyte-derived opioid peptides and inhibition of pain | Q37015399 | ||
| Variations in opioid responsiveness | Q37114615 | ||
| Pain and the immune system. | Q37132538 | ||
| Standard therapy with opioids in chronic pain management : ORTIBER study | Q39300701 | ||
| Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain | Q39395812 | ||
| Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial | Q39399521 | ||
| GABA in morphine analgesia and tolerance | Q39494950 | ||
| Drug interactions of clinical significance with opioid analgesics | Q40895607 | ||
| Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine | Q41611878 | ||
| Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. | Q42657899 | ||
| Opioid reward mechanisms: a key role in drug abuse? | Q43070837 | ||
| Trends in opioid consumption in the Nordic countries 2002-2006. | Q43435244 | ||
| Antidepressants increase bioavailability of morphine in cancer patients | Q43533072 | ||
| Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine | Q44337320 | ||
| Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo | Q44340066 | ||
| Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations | Q44340761 | ||
| Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. | Q44348612 | ||
| Interactions between benzodiazepines and opioids | Q44754148 | ||
| Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain | Q44862502 | ||
| The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain | Q45037862 | ||
| Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy | Q46950147 | ||
| Contribution of brainstem GABA(A) synaptic transmission to morphine analgesic tolerance | Q46983237 | ||
| The rise of opiophobia: is history a barrier to prescribing? | Q47189299 | ||
| Transdermal fentanyl: clinical pharmacology. | Q51693955 | ||
| Morphine and oxycodone hydrochloride in the management of cancer pain. | Q51735613 | ||
| Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care | Q71017710 | ||
| Opioids in Italy: is marketing more powerful than the law? | Q73643592 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 3-16 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose | |
| P478 | volume | 29 Suppl 1 |
| Q36152849 | A new real-time method for detecting the effect of fentanyl using the preoperative pressure pain threshold and Narcotrend index: a randomized study in female surgery patients |
| Q39260209 | Disaster after the plaster. Fentanyl withdrawal symptoms in a curable hospice patient |
| Q39181539 | Effective Dose Titration of Fentanyl Sublingual Spray in Patients With Breakthrough Cancer Pain |
| Q42952523 | Effects of opioid rotation in chronic pain patients: ORTIBARN study |
| Q37599814 | Guidelines for prescribing opioids for chronic non-cancer pain in Korea |
| Q64078167 | Healthcare professionals' perceptions on the use of opioid analgesics for the treatment of cancer-related pain in Cyprus: A mixed-method study |
| Q37742613 | Morphine/naltrexone |
| Q34773536 | Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions |
| Q37776491 | Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain. |
| Q39173147 | Retrospective Evaluation of a Fixed-Dose Combination of Oxycodone and Acetaminophen to Manage Moderate Pain: The Lower the Better |
| Q39279541 | Time to pain relief after immediate-release morphine in episodic pain: the TIME study. |
| Q37205128 | To predict sufentanil requirement for postoperative pain control using a real-time method: A prospective observational cohort study |
Search more.